RVMD PEER ANALYSIS

Revolution Medicines Inc — metric-by-metric comparison with peers and the industry median

RVMDRevolution Medicines Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

RVMDIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	RVMD	CSL	TLX	MSB	Ind. Median
P/E	—	30.02	—	—	17.81
P/B	25.09	2.24●	6.56	—	3.49
EV/EBITDA	—	10.37●	123.31	—	14.92
P/S	—	2.67●	3.34	31.91	10.89

Financial Health
Metric	RVMD	CSL	TLX	MSB	Ind. Median
Current Ratio	6.80●	2.57	1.43	—	5.90
Debt/Equity	29.2%●	67.4%	112.3%	—	10.9%
NetDebt/EBITDA	1.12●	2.22	13.13	—	1.15

Profitability
Metric	RVMD	CSL	TLX	MSB	Ind. Median
Net Margin	—	9.2%●	-0.9%	-115.3%	-125.7%
ROE	-76.7%	7.7%●	-1.8%	-11.3%	-47.5%
ROA	-59.4%	3.8%●	-0.7%	-8.6%	-35.8%
EBITDA Margin	—	32.8%●	3.0%	-76.6%	-105.8%

Growth + Dividend
Metric	RVMD	CSL	TLX	MSB	Ind. Median
Rev. Growth	-100.0%	4.8%	56.3%	410.4%●	5.1%
NI Growth	—	-39.4%	—	—	12.1%
Div. Yield	—	2.5%●	—	0.0%	0.2%
Payout	—	103.1%	—	0.0%	0.0%

Valuation
Metric	RVMD	ALNY	RPRX	MRNA	ROIV	INCY	Ind. Median
P/E	—	74.96	38.49	—	—	16.70●	17.81
P/B	25.09	40.24	4.62	4.36	6.35	4.31●	3.49
EV/EBITDA	—	44.93	23.66	—	—	10.65●	14.92
P/S	—	10.09	13.05	14.52	3,480.25	4.46●	10.89

Financial Health
Metric	RVMD	ALNY	RPRX	MRNA	ROIV	INCY	Ind. Median
Current Ratio	6.80	3.13	2.66	2.41	18.37●	3.68	5.90
Debt/Equity	29.2%	118.4%	130.0%	17.5%	2.4%	0.6%●	10.9%
NetDebt/EBITDA	1.12	-1.88	4.91	1.35	16.03	-2.13●	1.15

Profitability
Metric	RVMD	ALNY	RPRX	MRNA	ROIV	INCY	Ind. Median
Net Margin	—	13.5%	33.9%●	-143.6%	-3,629.2%	26.7%	-125.7%
ROE	-76.7%	96.9%●	12.2%	-36.6%	-6.5%	31.1%	-47.5%
ROA	-59.4%	12.4%	4.4%	-26.4%	-5.4%	21.9%●	-35.8%
EBITDA Margin	—	21.6%	69.6%●	-129.7%	-3,162.6%	34.9%	-105.8%

Growth + Dividend
Metric	RVMD	ALNY	RPRX	MRNA	ROIV	INCY	Ind. Median
Rev. Growth	-100.0%	82.6%●	7.8%	-29.1%	-67.7%	21.5%	5.1%
NI Growth	—	—	-24.3%	—	—	6,631.4%●	12.1%
Div. Yield	—	—	1.6%	—	—	—	0.2%
Payout	—	—	46.8%	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on RVMD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.